214 related articles for article (PubMed ID: 25712221)
1. Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen.
Kolawole AO; Hixon BP; Dameron LS; Chrisman IM; Smirnov VV
Arch Biochem Biophys; 2015 Mar; 570():47-57. PubMed ID: 25712221
[TBL] [Abstract][Full Text] [Related]
2. Substrate Oxidation by Indoleamine 2,3-Dioxygenase: EVIDENCE FOR A COMMON REACTION MECHANISM.
Booth ES; Basran J; Lee M; Handa S; Raven EL
J Biol Chem; 2015 Dec; 290(52):30924-30. PubMed ID: 26511316
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of substrate inhibition in human indoleamine 2,3-dioxygenase.
Efimov I; Basran J; Sun X; Chauhan N; Chapman SK; Mowat CG; Raven EL
J Am Chem Soc; 2012 Feb; 134(6):3034-41. PubMed ID: 22299628
[TBL] [Abstract][Full Text] [Related]
4. Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1.
Lewis-Ballester A; Karkashon S; Batabyal D; Poulos TL; Yeh SR
J Am Chem Soc; 2018 Jul; 140(27):8518-8525. PubMed ID: 29897749
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis of Selective Human Indoleamine-2,3-dioxygenase 1 (hIDO1) Inhibition.
Kassab SE; Mowafy S
ChemMedChem; 2021 Oct; 16(20):3149-3164. PubMed ID: 34174026
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase.
Lu C; Lin Y; Yeh SR
Biochemistry; 2010 Jun; 49(24):5028-34. PubMed ID: 20476772
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.
Lu C; Lin Y; Yeh SR
J Am Chem Soc; 2009 Sep; 131(36):12866-7. PubMed ID: 19737010
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase.
Lewis-Ballester A; Forouhar F; Kim SM; Lew S; Wang Y; Karkashon S; Seetharaman J; Batabyal D; Chiang BY; Hussain M; Correia MA; Yeh SR; Tong L
Sci Rep; 2016 Oct; 6():35169. PubMed ID: 27762317
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase.
Pham KN; Lewis-Ballester A; Yeh SR
J Am Chem Soc; 2019 Nov; 141(47):18771-18779. PubMed ID: 31682426
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase.
Basran J; Booth ES; Lee M; Handa S; Raven EL
Biochemistry; 2016 Dec; 55(49):6743-6750. PubMed ID: 27951658
[TBL] [Abstract][Full Text] [Related]
11. Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1.
Pantouris G; Serys M; Yuasa HJ; Ball HJ; Mowat CG
Amino Acids; 2014 Sep; 46(9):2155-63. PubMed ID: 24875753
[TBL] [Abstract][Full Text] [Related]
12. UV Resonance Raman Characterization of a Substrate Bound to Human Indoleamine 2,3-Dioxygenase 1.
Yanagisawa S; Kayama K; Hara M; Sugimoto H; Shiro Y; Ogura T
Biophys J; 2019 Aug; 117(4):706-716. PubMed ID: 31405517
[TBL] [Abstract][Full Text] [Related]
13. 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase.
Cady SG; Sono M
Arch Biochem Biophys; 1991 Dec; 291(2):326-33. PubMed ID: 1952947
[TBL] [Abstract][Full Text] [Related]
14. Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase.
Capece L; Arrar M; Roitberg AE; Yeh SR; Marti MA; Estrin DA
Proteins; 2010 Nov; 78(14):2961-72. PubMed ID: 20715188
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of L- and D-5-[
Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
[TBL] [Abstract][Full Text] [Related]
16. The role of serine 167 in human indoleamine 2,3-dioxygenase: a comparison with tryptophan 2,3-dioxygenase.
Chauhan N; Basran J; Efimov I; Svistunenko DA; Seward HE; Moody PC; Raven EL
Biochemistry; 2008 Apr; 47(16):4761-9. PubMed ID: 18370410
[TBL] [Abstract][Full Text] [Related]
17. Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2.
Lee YK; Lee HB; Shin DM; Kang MJ; Yi EC; Noh S; Lee J; Lee C; Min CK; Choi EY
Exp Mol Med; 2014 Nov; 46(11):e121. PubMed ID: 25394548
[TBL] [Abstract][Full Text] [Related]
18. Substrate binding in human indoleamine 2,3-dioxygenase 1: A spectroscopic analysis.
Nienhaus K; Nickel E; Nienhaus GU
Biochim Biophys Acta Proteins Proteom; 2017 Apr; 1865(4):453-463. PubMed ID: 28189796
[TBL] [Abstract][Full Text] [Related]
19. Fully automated radiosynthesis of N(1)-[(18)F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging.
Henrottin J; Lemaire C; Egrise D; Zervosen A; Van den Eynde B; Plenevaux A; Franci X; Goldman S; Luxen A
Nucl Med Biol; 2016 Jun; 43(6):379-89. PubMed ID: 27260779
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
